SCHEMBL6273192

SCHEMBL6273192

[CH]1CCCC(OC2CCCC2)C1

nearest known ligand 0.31

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CA12 O43570 2/20 0.31
CA1 P00915 2/20 0.31
CA2 P00918 2/20 0.31
CA9 Q16790 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7690541 0.83
SCHEMBL18632223 0.78 CA1 (0.33) CA12CA1CA2CA9
SCHEMBL510834 0.76 CA1 (0.36) CA12CA1CA2CA9
SCHEMBL20515207 0.74
SCHEMBL20515219 0.74
SCHEMBL217699 0.74
SCHEMBL3273348 0.73 CA1 (0.35) CA12CA1CA2CA9
Phosphine SCHEMBL22634022 0.73 CA1 (0.35) CA12CA1CA2CA9
SCHEMBL10775019 0.73 CA1 (0.41) CA12CA1CA2CA9
SCHEMBL9725970 0.73 CA1 (0.41) CA12CA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005117869-A1 COMBINATIONS COMPRISING (S)-AMLODIPINE AND A CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITOR, AND METHODS FOR REDUCING HYPERTENSION SEPRACOR INC. (US) 2005-12-15 WO disclosed